+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Short and Long-Term Postoperative Complications Following Total Joint Arthroplasty in Patients With Human Immunodeficiency Virus, Hepatitis B, or Hepatitis C

Short and Long-Term Postoperative Complications Following Total Joint Arthroplasty in Patients With Human Immunodeficiency Virus, Hepatitis B, or Hepatitis C

Journal of Arthroplasty 33(7s): S86

Due to advancement in treatment against human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV), the prevalence of this patient population electing to undergo total joint arthroplasty (TJA) is increasing. Current literature is scarce and conflicting especially when evaluating long-term surgical complications. The purpose of this study is to assess the postoperative medical and surgical complications following TJA in these patient populations. Using a nationwide database between 2005 and 2012, 4 cohorts were created: patients with HIV, HCV, HBV, and HIV and HBV or HCV who underwent TJA. Cohorts were matched to a control group by age, gender, and Charlson Comorbidity Index. Thirty-day and 90-day medical complications and 90-day and 2-year surgical complications were evaluated using odds ratios with 95% confidence intervals. Following TJA, patients with HCV or HBV had increased risk of pneumonia, sepsis, joint infection, and revision surgery at 90 days and 2 years. Patients with HIV did not have increased risk of infection at 90 days and 2 years but did have increased risk of revision at 90 days (odds ratio 3.21, 95% confidence interval 1.31-7.84) following total hip arthroplasty. Patients with HIV, HBV, or HCV have an overall increased risk of postoperative medical and surgical complications following TJA. Patients with HBV or HCV are at risk of more complications than patients with HIV especially for infection within 90 days after TJA. Patients with HIV are at risk of mechanical complications but do not appear to be at significant risk for infection following total hip arthroplasty.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 065510824

Download citation: RISBibTeXText

PMID: 29198873

DOI: 10.1016/j.arth.2017.10.061

Related references

The Impact of Hepatitis C on Short-Term Outcomes of Total Joint Arthroplasty. Journal of Bone and Joint Surgery. American Volume 97(23): 1952-1957, 2015

Correlation of hepatitis b virus hepatitis d virus and human immunodeficiency virus type i infection markers in hepatitis b surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis. European Journal of Pediatrics 151(2): 90-94, 1992

Low prevalence of hepatitis B virus, hepatitis D virus and hepatitis C virus among patients with human immunodeficiency virus or acquired immunodeficiency syndrome in the Brazilian Amazon basin. Revista Da Sociedade Brasileira de Medicina Tropical 39(6): 519-522, 2006

Role of hepatitis C virus superinfection in hepatic pathologic changes of patients with chronic hepatitis B: a retrospective short-term and long-term comparative study. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 19(1): 32-34, 2005

Fibrosis in hepatitis C patients predicts complications after elective total joint arthroplasty. Journal of Arthroplasty 29(1): 7-10, 2014

Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term. Hepatology 61(5): 1503-1511, 2015

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology 30(5): 1302-1306, 1999

Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology 139(6): 1934-1941, 2010

Profile of hepatitis B virus, hepatitis C virus, hepatitis d virus and human immunodeficiency virus infections in hemodialysis patients of a tertiary care hospital in uttarakhand. Journal of Clinical and Experimental Hepatology 3(1): 24-28, 2013

Emergence of resistant hepatitis B virus strains during long-term lamivudine therapy in human immunodeficiency virus co-infected patients. Gastroenterologie Clinique et Biologique 24(1): 125-127, 2000

Total Joint Arthroplasty in Patients with Human Immunodeficiency Virus. Jbjs Reviews 4(11):, 2016

Cardiac surgery in patients chronically infected with hepatitis C virus: long-term outcomes and comparison to historical controls and human immunodeficiency virus infection. Journal of Cardiovascular Surgery 57(4): 598-605, 2016

Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients. Journal of Clinical Virology 57(2): 103-108, 2013

Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence. Hepatology 51(3): 1087-1088, 2010

Human Leukocyte Antigen-E Alleles are Associated with Hepatitis C Virus, Torque Teno Virus, and Toxoplasma Co-infections but are not Associated with Hepatitis B Virus, Hepatitis D Virus, and GB Virus C Co-infections in Human Immunodeficiency Virus Patients. Journal of Global Infectious Diseases 8(2): 75-81, 2016